Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats

British Journal of Pharmacology

Volumn 168, Issue 4, 2013, Pages 850-862

  Bauer, C T ^a   Banks, M L ^a   Blough, B E ^b   Negus, S S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

amphetamine; dopamine; fenfluramine; ICSS; methylenedioxymethylamphetamine; serotonin

Indexed keywords

AMPHETAMINE; DOPAMINE; FENFLURAMINE; METHAMPHETAMINE; MONOAMINE; PHENMETRAZINE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPAMINE RELEASE; DRUG ABUSE; DRUG SELF ADMINISTRATION; FACILITATION; MALE; MONOAMINE RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SELF STIMULATION; SEROTONIN RELEASE;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; DEEP BRAIN STIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SELF STIMULATION; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84872952304     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02214.x     Document Type: Article

References (54)

1. Altarifi AA, Negus SS, (2011). Some determinants of morphine effects on intracranial self-stimulation in rats: dose, pretreatment time, repeated treatment, and rate dependence. Behav Pharm 22: 663-673.
2. Ator NA, Griffiths RR, (2003). Principles of drug abuse and liability assessment in laboratory animals. Drug Alcohol Depend 70 (Suppl. 3): S55-S72.
3. Balster RL, Bigelow GE, (2003). Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend 70 (Suppl. 5): S13-S40.
4. Balster RL, Schuster CR, (1973). A comparison of d-Amphetamine, l-Amphetamine, and methamphetamine self-Administration in rhesus monkeys. Pharmacol Biochem Behav 1: 67-71.
5. Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB, (2011). In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. JPET 337: 218-225.
6. Bray GA, (1993). Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med 119: 707-713.
7. Carlezon WA, Chartoff EH, (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2: 2987-2995.
8. Corwin RL, Woolverton WL, Schuster CR, Johanson CE, (1987). Anorectics: effects on food intake and self-Administration in rhesus monkeys. Alcohol Drug Res 7: 351-361.
9. Dahl CB, Götestam KG, (1989). Lack of self-Administration of different fenfluramine isomers in rats. Addict Behav 14: 239-247.
10. Do Carmo GP, Folk JE, Rice KC, Chartoff E, Carlezon WA Jr, Negus SS, (2009). The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol 604: 58-65.
11. Elder ST, Noel PM, Merrill MR, (1965). Effects of Food Deprivation and Methamphetamine on Fixed-Ratio Schedules of Intracranial Self-Stimulation. Psychol Rep 16: 1225-1233.
12. Elmer GI, Pieper JO, Hamilton LR, Wise RA, (2010). Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-Administration. Psychopharmacology (Berl) 208: 309-321.
13. Esposito RU, Perry W, Kornetsky C, (1980). Effects of d-Amphetamine and naloxone on brain stimulation reward. Psychopharmacology 69: 187-191.
14. Götestam KG, Andersson BE, (1975). Self-Administration of amphetamine analogues in rats. Pharmacol Biochem Behav 3: 229-233.
15. Grabowski J, Shearer J, Merrill J, Negus SS, (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29: 1439-1464.
16. Griffiths RR, Winger G, Brady JV, Snell JD, (1976). Comparison of behavior maintained by infusions of eight phenylethylamines in baboons. Psychopharmacology (Berl) 50: 251-258.
17. Howell LL, Kimmel HL, (2008). Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75: 196-217.
18. Hubner CB, Bird M, Rassnick S, Kornetsky C, (1988). The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology (Berl) 95: 49-51.
19. Jasinski DR, Kovacevic̈-Ristanovic̈ R, (2000). Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol 23: 149-156.
20. Kling-Petersen T, Ljung E, Svensson K, (1994). The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-Amphetamine in the ICSS paradigm. Pharmacol Biochem Behav 49: 345-351.
21. Kornetsky C, Esposito RU, (1979). Euphorigenic drugs: effects on the reward pathways of the brain. Fed Proc 38: 2473-2476.
22. Lattal KA, (2010). Delayed reinforcement of operant behavior. J Exp Anal Behav 93: 129-139.
23. Leung KS, Cottler LB, (2008). Ecstasy and other club drugs: a review of recent epidemiologic studies. Curr Opin Psychiatry 21: 234-241.
24. Lin D, Koob GF, Markou A, (2000). Time-Dependent Alterations in ICSS Thresholds Associated With Repeated Amphetamine Administrations. Pharmacol Biochem Behav 65: 407-417.
25. Lin HQ, Jackson DM, Atrens DM, Christie MJ, McGregor IS, (1997). Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation. Brain Res 744: 351-357.
26. McGrath J, Drummond G, Kilkenny C, Wainwright C, (2010). Guidelines for reportingexperiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
27. McKenna ML, Ho BT, (1980). The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology 19: 297-303.
28. Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D, (1986). The curve-shift paradigm in self-stimulation. Physiol Behav 37: 85-91.
29. National Academy of Science (1996). Guide for the Care and Use of Laboratory Animals, 7th edn. National Academy Press: Washington, DC.
30. Negus SS, Morrissey EM, Rosenberg M, Cheng K, Rice KC, (2010). Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology 210: 149-159.
31. Nishino S, (2007). Clinical and neurobiological aspects of narcolepsy. Sleep Med 8: 373-399.
32. O'Connor EC, Chapman K, Butler P, Mead AN, (2011). The predictive validity of the rat self-Administration model for abuse liability. Neurosci Biobehav Rev 35: 912-938.
33. Olds ME, (1995). Dopamine agonists prevent or counteract the suppression of brain stimulation reward by fenfluramine. Pharmacol Biochem Behav 50: 41-48.
34. Olds ME, Yuwiler A, (1992). Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine. Eur J Pharmacol 216: 363-372.
35. Parada M, Hernandez L, Schwartz D, Hoebel BG, (1988). Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine. Physiol Behav 44: 607-610.
36. Richardson NR, Roberts DCS, (1996). Progressive ratio schedules in drug self-Administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11.
37. Rothman RB, Baumann MH, (2006). Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci 1074: 245-260.
38. Rothman RB, Blough BE, Baumann MH, (2007). Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J 9: 1-10.
39. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, et al. (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41.
40. Rothman RB, Katsnelson M, Vu N, Partilla JS, Dersch CM, Blough BE, et al. (2002). Interaction of the anorectic medication, phendimetrazine, and its metabolites with monoamine transporters in rat brain. Eur J Pharmacol 447: 51-57.
41. Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, et al. (2005). Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-Administration. JPET 313: 1361-1369.
42. Setlik J, Bond GR, Ho M, (2009). Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications. Pediatrics 124: 875-880.
43. Sills TL, Greenshaw AJ, Baker GB, Fletch PJ, (1999). Acute fluoxetine treatment potentiates amphetamine hyperactivity and amphetamine-induced nucleus accumbens dopamine release: possible pharmacokinetic interaction. Psychopharmacology 141: 421-427.
44. Stafford D, LeSage MG, Glowa JR, (1998). Progressive-ratio schedules of drug delivery in the analysis of drug self-Administration: a review. Psychopharmacology 139: 169-184.
45. Stoops WW, (2008). Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. Exp Clin Psychopharmacol 16: 503-512.
46. Vlachou S, Markou A, (2011). Intracranial self-stimulation. Anim Models Drug Addict 53: 3-56.
47. Wang Z, Woolverton WL, (2007). Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine. Psychopharmacology 189: 483-488.
48. Wee S, Woolverton WL, (2006). Self-Administration of mixtures of fenfluramine and amphetamine by rhesus monkeys. Pharmacol Biochem Behav 84: 337-343.
49. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, Woolverton WL, (2005). Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. JPET 313: 848-854.
50. Winder GS, Stern N, Hosanagar A, (2012). Are 'Bath Salts' the next generation of stimulant abuse? J Subst Abuse Treat. In Press. Available at: http://dx.doi.org/10.1016/j.jsat.2012.02.003 (accessed 19 October 2012).
51. Wise RA, (1996). Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19: 319-340.
52. Wise RA, Munn E, (1995). Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology 117: 130-136.
53. Woods JH, Tessel RE, (1974). Fenfluramine: amphetamine congener that fails to maintain drug-taking behavior in the rhesus monkey. Science 185: 1067-1069.
54. Woolverton WL, Freeman KB, Myerson J, Green L, (2012). Suppression of cocaine self-Administration in monkeys: effects of delayed punishment. Psychopharmacology 220: 509-517.